CHI Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

CHI Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.27M	Hold	1,055,882	–	–	0.9%	20
2023 Q2	$5.91M	Hold	1,055,882	–	–	1.79%	12
2023 Q1	$6.37M	Hold	1,055,882	–	–	1.69%	11
2022 Q4	$6.03M	Hold	1,055,882	–	–	1.61%	10
2022 Q3	$5.72M	Hold	1,055,882	–	–	1.54%	12
2022 Q2	$4.01M	Hold	1,055,882	–	–	1.53%	14
2022 Q1	$6.59M	Hold	1,055,882	–	–	2.8%	7
2021 Q4	$12M	Hold	1,055,882	–	–	3.97%	7
2021 Q3	$19.9M	Buy	+1,055,882	New	+$20.3M	5.81%	6

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CHI Advisors's OMGA Position: Q3 2023 in Review

CHI Advisors held its Omega Therapeutics, Inc. Common Stock (OMGA) position steady in Q3 2023 at 1,055,882 shares worth $2.27M. The position accounts for 0.9% of the portfolio, ranked #20.

CHI Advisors first reported a position in OMGA in Q3 2021 and has held it in 9 quarters since. The position peaked at $19.9M in Q3 2021. 58 funds tracked by Wall St. Rank hold OMGA as of Q3 2023.

CHI Advisors held 1,055,882 shares of Omega Therapeutics, Inc. Common Stock worth $2.27M as of Q3 2023.
CHI Advisors left its Omega Therapeutics, Inc. Common Stock share count unchanged in Q3 2023.
Omega Therapeutics, Inc. Common Stock made up 0.9% of CHI Advisors's portfolio in Q3 2023, its #20 holding.
CHI Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and has held it in 9 quarters since.
CHI Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $19.9M in Q3 2021.
58 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.